Work

Abstract S3-03: Ten year update of E1199: Phase III study of doxorubicin-cyclophosphamide followed by paclitaxel or docetaxel given every 3 weeks or weekly in patients with axillary node-positive or high-risk node-negative breast cancer

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-s3-03

Authors: Joseph A Sparano, Fengmin Zhao, Silvana Martino, Jennifer Ligibel, Thomas Saphner, Antonio C Wolff, George W Sledge, Edith A Perez, William C Wood, Nancy E Davidson

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, Dana-Farber Cancer Institute, Johns Hopkins University, Stanford University, Mayo Clinic, Emory University, University of Pittsburgh

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1602406797

Cites:

Cited by: 6

Related to: 10